In the European Health Data Space, how can the European electronic health record format (“the format”) be used by public health institutes to work on anti-microbial resistance? EHTEL’s digital health facilitator, Luc Nicolas, is working on this topic in the context of the xShare project.
Among the 20 different aspects of the anti-microbial business use case, one section describes products and services that are currently available and their vendors.
What is the xShare project working on overall?
xShare, a large European project, aims to set new standards and enable patients to share their own health data. Patients can do this via the European Electronic Health Record Exchange Format (EEHRxF) (“the format”) specifications defined under the European Health Data Space (EHDS) legislation.
xShare’s has eight adoption sites (each in different countries). The sites develop and demonstrate how a patient can share their data, by simply clicking on a Yellow Button. Well-documented business use cases form the foundation of the work to be done on the adoption sites.
Each business use case describes how end-users use a system in a specific Health Information Domain (like a Patient Summary). As a result, xShare is establishing collections of digital services (called xBundles) to operationalise each business use case. An xBundle is a “targeted aggregation of assets (and artifacts) that support interoperability [in] and between health systems”.
What is the xShare project doing on anti-microbial resistance?
xShare is developing a whole set of business use cases.
The first of the nine use cases is on anti-microbial resistance.
With the EEHRxF (“the format”), data from laboratories as well as information on antimicrobial consumption could be made available in almost real-time at both a national level and at international level for public health purposes.
Positively, this availability would occur without error-prone data transformations. Hence, data could be used for real-time monitoring and for anticipating critical anti-microbial challenges. It would enable timely decision-making and prompt interventions.
For more information
xShare’s business use case on anti-microbial resistance
